These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21383281)

  • 1. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis.
    Valsecchi ME; Silbermins D; de Rosa N; Wong SL; Lyman GH
    J Clin Oncol; 2011 Apr; 29(11):1479-87. PubMed ID: 21383281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sentinel lymph node biopsy in patients with cutaneous malignant melanoma].
    Gad D; Sjøgren P
    Ugeskr Laeger; 2003 Jun; 165(25):2567-70. PubMed ID: 12854268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
    Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
    J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
    Creager AJ; Shiver SA; Shen P; Geisinger KR; Levine EA
    Cancer; 2002 Jun; 94(11):3016-22. PubMed ID: 12115392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
    Glumac N; Hocevar M; Zadnik V; Snoj M
    J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Feasibility and technical problems of sentinel node analysis in melanoma].
    Mebazaa A; Kerob D; Toubert ME; Verola O; Servant JM; Baccard M; Billotey C; Bustamante K; Vandici FO; Basset-Seguin N; Ollivaud L; Morel P; Lebbé C
    Ann Chir Plast Esthet; 2007 Feb; 52(1):14-23. PubMed ID: 17141391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for false negative sentinel lymph node in melanoma patients.
    Panasiti V; Devirgiliis V; Curzio M; Roberti V; Gobbi S; Rossi M; Bottoni U; Clerico R; Scuderi N; Calvieri S
    Dermatol Surg; 2010 Oct; 36(10):1521-8. PubMed ID: 20698871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of nonsentinel lymph node metastasis in malignant melanoma.
    Cadili A; Smylie M; Danyluk J; Dabbs K
    J Surg Res; 2009 Jun; 154(2):324-9. PubMed ID: 19101696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?
    Morton DL; Scheri RP; Balch CM
    Ann Surg Oncol; 2007 Sep; 14(9):2437-9. PubMed ID: 17574500
    [No Abstract]   [Full Text] [Related]  

  • 17. An aberrant lymph node containing metastatic melanoma detected by sentinel node biopsy.
    Moloney DM; Overstall S; Allan R; Powell BW
    Br J Plast Surg; 2001 Oct; 54(7):638-40. PubMed ID: 11583504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
    Wilson LL
    Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
    Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.